Fundraising Fox

3T Biosciences

South San Francisco, US · 4 known investors

3tbiosciences.com ↗

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets. The company creates therapeutic treatments targeting cancer and other difficult-to-treat diseases.

AI & Machine LearningBiotechHealthtechMedical Devicesin /3tbiosciences@3tbio

Founders & leadership

KC
K. Christopher Garcia

Investors · 4

Asset Management CompanyPalo Alto
CRV (Charles River Ventures)San Francisco
Westlake Village BioPartnersLos Angeles
Menlo VenturesreportedMenlo Park

In the news